Engineered immune cells targeted and reduced the toxic protein plaques that drive Alzheimer’s disease in a recent study.

In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.

A Lancashire dad-of-four who was told his leg pain was sciatica was later diagnosed with an aggressive cancer - and given just months to live.

A handful of small, early-stage clinical trials are investigating whether CAR-T therapy can improve symptoms in multiple ...

I recently found out that my aunt was diagnosed with cancer and may need chemotherapy. When I think of chemotherapy, I ...

Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...

Giahan Tang thought she was finally finding stability after college when unusual symptoms led to a shock diagnosis of stage 4 diffuse large B-cell lymphoma After an ER visit initially blamed on an ...

The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...

Encouraging preclinical and translational data supporting DNase-based approaches to target NETs in difficult-to-treat ...

Operator: Hello, and thank you for standing by. Welcome to Allogene Therapeutics, Inc. Fourth Quarter 2025 Conference Call.

Cancer treatment is hard enough without bureaucratic and policy hurdles, two doctors argue. Better advocacy is necessary.